Terms: = Breast cancer AND MLLT6, AF17, 4302, ENSG00000108292, P55198 AND Treatment
2 results:
1. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study.
Güven DC; Yıldırım HÇ; Erul E; Şahin TK; Çakır İY; Aktepe OH; Kertmen N; Dizdar Ö; Aksoy S
Turk J Med Sci; 2022 Oct; 52(5):1551-1558. PubMed ID: 36422490
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Pathways: The Balance between cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for cancer treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract] [Full Text] [Related]
